ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

STAF Staffline Group Plc

33.20
0.45 (1.37%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Staffline Group Plc LSE:STAF London Ordinary Share GB00B040L800 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.45 1.37% 33.20 32.50 33.90 - 74,727 16:35:21
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Management Consulting Svcs 938.2M -11M -0.0664 -4.93 54.29M
Staffline Group Plc is listed in the Management Consulting Svcs sector of the London Stock Exchange with ticker STAF. The last closing price for Staffline was 32.75p. Over the last year, Staffline shares have traded in a share price range of 22.00p to 40.90p.

Staffline currently has 165,768,000 shares in issue. The market capitalisation of Staffline is £54.29 million. Staffline has a price to earnings ratio (PE ratio) of -4.93.

Staffline Share Discussion Threads

Showing 21251 to 21271 of 28200 messages
Chat Pages: Latest  852  851  850  849  848  847  846  845  844  843  842  841  Older
DateSubjectAuthorDiscuss
22/3/2021
10:39
Price has recovered and volume looks good.
john09
22/3/2021
10:26
I have to walk like John Wayne because of all the cash in my pockets
john09
22/3/2021
10:23
Gripfit had me up all night and now im walking like John Wayne :(
jimbarlow78
22/3/2021
10:22
He left at 6 this morning, said he was off to work....
gripfit
22/3/2021
10:21
Slept in? That’s not like you 😏
john09
22/3/2021
10:19
Lol. Im actually a bit hacked off cos I slept in and missed the dip! Wont surprise me one bit if this is blue shortly.
jimbarlow78
22/3/2021
10:18
your going from novice to Ace in months Jim,,lolo
gripfit
22/3/2021
09:57
Brilliant hoppy this is going to fall to 60p soon enough....

Hardly a tree shake when the mms won't take stock but will sell bucket loads says it all.

🎋🌳🌴🌲 8745;💥

qsmeily456
22/3/2021
09:50
Yes i think a tree shaker. This volume on a monday morning very unusual. This afternoon it will recover
busthief2
22/3/2021
09:34
morning ladies
gutterhead
22/3/2021
09:24
You would then expect mm to push up the price knowing that these people need to cover their positions. I don't think the drop was related to that.It was a drop to hit stop losses otherwise known as a tree shaker
mubz
22/3/2021
09:21
I wonder if any of this is linked to IG withdrawing from making a market?

STAF went to 100% margin requirement a while back, but even those that ponied up the funds have to close their positions by 26.03 else IG will do it for them the week after

nav_mike
22/3/2021
09:09
Hows your imaginary short doing?
maryhopkins
22/3/2021
09:08
Looks like stop losses have been hit
mubz
22/3/2021
09:03
Clearly a seller willing to sell cheap
mubz
22/3/2021
08:56
🔧🔧🔧

john09

22 Mar '21 - 08:08 - 5168 of 5176

0  0 0

Tremor trading ahead . Yep nice start 8% out of the blocks

Expecting a good day for many stocks today

qsmeily456
22/3/2021
08:56
this has made the chart look even better.
gripfit
22/3/2021
08:54
Woohooo....🍾🥂

60p test.....💥

qsmeily456
22/3/2021
08:47
Jim ,, don’t look .....
gripfit
22/3/2021
08:22
Think I would be banking them profits in tremor now John
gripfit
22/3/2021
08:16
Big news

AstraZeneca’s US clinical trial of its Covid-19 vaccine developed with Oxford university has shown 79 per cent efficacy at preventing symptomatic disease and 100 per cent efficacy against severe or critical disease and hospitalisation.

A fifth of the participants in the trial were over the age of 65 and the jab showed 80 per cent efficacy in these older participants, the long-awaited results showed on Monday.

The AstraZeneca vaccine is currently embroiled in a safety row in Europe, with some countries pausing its rollout after registering a series of rare side events involving a specific type of blood clot.

The European regulator, the European Medicines Agency, has said throughout the safety crisis that the vaccine’s benefits far outweigh its risks, but some countries have opted to halt the rollout, pending more data.

Crucially, the US trial found the vaccine was well tolerated, AstraZeneca said, and the independent data safety monitoring board identified no safety concerns related to the vaccine.

john09
Chat Pages: Latest  852  851  850  849  848  847  846  845  844  843  842  841  Older

Your Recent History

Delayed Upgrade Clock